Survival from uveal melanoma in England and Wales 1986 to 2001
- PMID: 17365812
- DOI: 10.1080/09286580600977281
Survival from uveal melanoma in England and Wales 1986 to 2001
Abstract
Purpose: To analyse survival from uveal melanoma diagnosed in England and Wales between 1986-1999 and followed up to 2001.
Methods: Data from the National Cancer Registry at the Office for National Statistics were analysed. The data were compiled from population-based cancer registries covering all of England and Wales for all adults (aged 15-99) diagnosed with primary ocular malignancy, excluding eyelid tumours. Level of poverty was based on the national classification of area of residence at time of diagnosis. Regression models explored the influence of sex, age, and level of poverty on relative survival for patients diagnosed with uveal melanoma during successive calendar periods.
Results: Of 5,519 adults identified with primary ocular malignancy, 4,717 had melanoma, of which 4,308 (91%) were eligible for analysis. Two-thirds (67%) of the ocular melanomas were uveal, 5% conjunctival, and 2% orbital; the subsite was unspecified in 26%. Relative survival from uveal melanoma was 95% at 1 year and 72% at 5 years. There was no statistically significant variation in 1-year or 5-year survival by sex or poverty level and no significant trend over time. Older patients had significantly worse survival (p < 0.001).
Conclusions: This study provides national population-based survival estimates for England and Wales for uveal melanoma, the most common primary intraocular malignancy in adults. Five-year relative survival, an important indicator of the quality of cancer care, has not improved since the 1980s. Greater age, but not gender or level of poverty, is associated with a poorer prognosis. A standardised classification of uveal melanoma is required to improve reporting to cancer registries. Further research is required to explore reasons for lower relative survival in older persons.
Similar articles
-
Uveal melanoma survival in Sweden from 1960 to 1998.Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3282-7. doi: 10.1167/iovs.03-0081. Invest Ophthalmol Vis Sci. 2003. PMID: 12882771
-
Survival from uveal melanoma in Western Australia 1981-2005.Clin Exp Ophthalmol. 2015 Jul;43(5):422-8. doi: 10.1111/ceo.12490. Epub 2015 Feb 12. Clin Exp Ophthalmol. 2015. PMID: 25556534
-
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.Eur J Cancer. 2012 May;48(8):1167-75. doi: 10.1016/j.ejca.2011.10.004. Epub 2011 Nov 25. Eur J Cancer. 2012. PMID: 22119735
-
Modelling uveal melanoma.Br J Ophthalmol. 1999 May;83(5):588-94. doi: 10.1136/bjo.83.5.588. Br J Ophthalmol. 1999. PMID: 10216060 Free PMC article.
-
Uveal melanoma: is solar ultraviolet radiation a risk factor?Ophthalmic Epidemiol. 1994 Mar;1(1):27-30. doi: 10.3109/09286589409071442. Ophthalmic Epidemiol. 1994. PMID: 8790610
Cited by
-
Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.JAMA Ophthalmol. 2020 Aug 1;138(8):876-884. doi: 10.1001/jamaophthalmol.2020.2254. JAMA Ophthalmol. 2020. PMID: 32614376 Free PMC article.
-
Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.BMC Ophthalmol. 2021 May 25;21(1):230. doi: 10.1186/s12886-021-01968-6. BMC Ophthalmol. 2021. PMID: 34030647 Free PMC article.
-
Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture.JAMA Ophthalmol. 2013 Apr;131(4):462-9. doi: 10.1001/jamaophthalmol.2013.2547. JAMA Ophthalmol. 2013. PMID: 23392528 Free PMC article.
-
Cytokines concentrations in aqueous humor of eyes with uveal melanoma.Medicine (Baltimore). 2019 Feb;98(5):e14030. doi: 10.1097/MD.0000000000014030. Medicine (Baltimore). 2019. PMID: 30702560 Free PMC article.
-
Global incidence and prevalence in uveal melanoma.Adv Ophthalmol Pract Res. 2024 Oct 9;4(4):226-232. doi: 10.1016/j.aopr.2024.10.001. eCollection 2024 Nov-Dec. Adv Ophthalmol Pract Res. 2024. PMID: 39726825 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical